Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Colonic Neoplasms 1

Interventions

Oxaliplatin 87Bevacizumab 68Capecitabine 65Fluorouracil 48tislelizumab 41Gemcitabine 41Drug Therapy 41Leucovorin 38sintilimab 36Irinotecan 35lenvatinib 28Cisplatin 27HMPL-013 24S 1 (combination) 23camrelizumab 22Immune Checkpoint Inhibitors 21irinotecan sucrosofate 20apatinib 20Surgical Procedures, Operative 20Radiotherapy 20Injections 20Paclitaxel 19130-nm albumin-bound paclitaxel 19toripalimab 18Folfox protocol 17pembrolizumab 15Immunotherapy 15Cetuximab 15Specimen Handling 14Radiosurgery 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × HLX07 × Gastrointestinal × Clear all
NCT07358585 2026-01-22

A Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer

Shanghai Henlius Biotech

Phase 1/2 Not yet recruiting
126 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡